VEGFA and neoplasm: Loss of CYLD stabilizes β-catenin and enhances β-catenin/TCF-mediated transcription, while BCL9 overexpression amplifies Wnt signaling, tumor cell proliferation, migration, and vascular endothelial growth factor (VEGF) expression, all of which may contribute to drug resistance [114].